(1-(4-FLUOROPHENYL)-4-METHYL-1H-1,2,3-TRIAZOL-5-YL)METHANOL, 95.0%, 250mg

1,3-Propanediol, min. 98%, for synthesis, 100 ml, glass packaging

5-Bromo-3-chloropyridine-2-carboxylic acid, 98.0%, 25g

4-Chloro-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidine, 97.0%, 1g

Potassium 2-bromo-2,2-difluoroacetate, 95.0%, 1g

2-Ethynyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>95.0%(GC)200mg

1,4-Diaza-spiro[5.5]undecane dihydrochloride, 97.0%, 1g

8-Carboxylic-3H-1,4-Benzodiazepin-2,5-(1H,4H)-dione, 97.0%, 5g

1-(1,3-thiazol-2-yl)-1H-pyrrole-2-carbaldehyde, 95.0%, 1g

4-(CYANOSULFANYL)-3-NITROBENZOIC ACID, 95.0%, 1g

Dicyclohexyl(2',6'-dimethoxy-[1,1'-biphenyl]-2-yl)phosphine, 98.0%, 100mg

tert-butyl 3-(cyclooctylamino)-2-methylpropanoate, 95.0%, 2g

Volumetric flasks DURAN® Class B, 1000 ml, 24/29, 2 Piece(s)